A Study of Two Forms of Pentamidine in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS

Completed · Not applicable

Conditions studied: Pneumonia, Pneumocystis Carinii, HIV Infections

In brief

To compare parenteral versus inhaled pentamidine in patients with documented Pneumocystis carinii pneumonia (PCP) with AIDS.

Key facts

Study ID

NCT00002292

Run by

LyphoMed

Last updated by the study team

2005-06-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may not qualify if…

• Co-existing Condition:
• Patients with the following are excluded:
• Previous history of adverse reaction to pentamidine.
• History of asthma.
• Pulmonary Kaposi's sarcoma.
• Patients with the following are excluded:
• Previous history of adverse reaction to pentamidine.
• History of asthma.
• Pulmonary Kaposi's sarcoma.
• Inability to understand the consent procedure.
• All patients hospitalized at Cedars-Sinai Medical Center with AIDS and possible Pneumocystis carinii pneumonia (PCP) will be eligible.
• Patients with HIV antibody or AIDS and a clinical presentation suggesting PCP are eligible.

Where it is running

• LyphoMed Inc — Rosemont, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.